181 related articles for article (PubMed ID: 31107304)
1. Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients.
Lo Re V; Newcomb CW; Carbonari DM; Roy JA; Althoff KN; Kitahata MM; Reddy KR; Lim JK; Silverberg MJ; Mayor AM; Horberg MA; Cachay ER; Kirk GD; Hull M; Gill J; Sterling TR; Kostman JR; Peters MG; Moore RD; Klein MB; Kim HN;
J Acquir Immune Defic Syndr; 2019 Sep; 82(1):71-80. PubMed ID: 31107304
[TBL] [Abstract][Full Text] [Related]
2. Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North America.
Kim HN; Newcomb CW; Carbonari DM; Roy JA; Torgersen J; Althoff KN; Kitahata MM; Reddy KR; Lim JK; Silverberg MJ; Mayor AM; Horberg MA; Cachay ER; Kirk GD; Sun J; Hull M; Gill MJ; Sterling TR; Kostman JR; Peters MG; Moore RD; Klein MB; Lo Re V;
Hepatology; 2021 Sep; 74(3):1190-1202. PubMed ID: 33780007
[TBL] [Abstract][Full Text] [Related]
3. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.
Klein MB; Althoff KN; Jing Y; Lau B; Kitahata M; Lo Re V; Kirk GD; Hull M; Kim HN; Sebastiani G; Moodie EE; Silverberg MJ; Sterling TR; Thorne JE; Cescon A; Napravnik S; Eron J; Gill MJ; Justice A; Peters MG; Goedert JJ; Mayor A; Thio CL; Cachay ER; Moore R; ;
Clin Infect Dis; 2016 Nov; 63(9):1160-1167. PubMed ID: 27506682
[TBL] [Abstract][Full Text] [Related]
4. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
Sun J; Althoff KN; Jing Y; Horberg MA; Buchacz K; Gill MJ; Justice AC; Rabkin CS; Goedert JJ; Sigel K; Cachay E; Park L; Lim JK; Kim HN; Lo Re V; Moore R; Sterling T; Peters MG; Achenbach CJ; Silverberg M; Thorne JE; Mayor AM; Crane HM; Kitahata MM; Klein M; Kirk GD;
JAMA Netw Open; 2021 Feb; 4(2):e2037512. PubMed ID: 33595662
[TBL] [Abstract][Full Text] [Related]
5. Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study.
Gjærde LI; Shepherd L; Jablonowska E; Lazzarin A; Rougemont M; Darling K; Battegay M; Braun D; Martel-Laferriere V; Lundgren JD; Rockstroh JK; Gill J; Rauch A; Mocroft A; Klein MB; Peters L
Clin Infect Dis; 2016 Sep; 63(6):821-829. PubMed ID: 27307505
[TBL] [Abstract][Full Text] [Related]
6. Liver-related Events in Human Immunodeficiency Virus-infected Persons With Occult Cirrhosis.
Benmassaoud A; Nitulescu R; Pembroke T; Halme AS; Ghali P; Deschenes M; Wong P; Klein MB; Sebastiani G
Clin Infect Dis; 2019 Sep; 69(8):1422-1430. PubMed ID: 30561558
[TBL] [Abstract][Full Text] [Related]
7. Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.
McMahon BJ; Bruden D; Townshend-Bulson L; Simons B; Spradling P; Livingston S; Gove J; Hewitt A; Plotnik J; Homan C; Espera H; Negus S; Snowball M; Barbour Y; Bruce M; Gounder P
Clin Gastroenterol Hepatol; 2017 Mar; 15(3):431-437.e2. PubMed ID: 27765729
[TBL] [Abstract][Full Text] [Related]
8. Association of Heavy Alcohol Intake and ALDH2 rs671 Polymorphism With Hepatocellular Carcinoma and Mortality in Patients With Hepatitis B Virus-Related Cirrhosis.
Tsai MC; Yang SS; Lin CC; Wang WL; Hsu YC; Chen YS; Hu JT; Lin JY; Yu ML; Lin CW
JAMA Netw Open; 2022 Jul; 5(7):e2223511. PubMed ID: 35877121
[TBL] [Abstract][Full Text] [Related]
9. Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.
Wandeler G; Mauron E; Atkinson A; Dufour JF; Kraus D; Reiss P; Peters L; Dabis F; Fehr J; Bernasconi E; van der Valk M; Smit C; Gjærde LK; Rockstroh J; Neau D; Bonnet F; Rauch A;
J Hepatol; 2019 Aug; 71(2):274-280. PubMed ID: 30965070
[TBL] [Abstract][Full Text] [Related]
10. Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection.
Lieveld FI; Smit C; Richter C; van Erpecum KJ; Spanier BWM; Gisolf EH; Vrolijk JM; Siersema PD; Hoepelman AIM; Reiss P; Arends JE
Liver Int; 2019 Mar; 39(3):470-483. PubMed ID: 30411848
[TBL] [Abstract][Full Text] [Related]
11. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
[TBL] [Abstract][Full Text] [Related]
12. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV.
Limketkai BN; Mehta SH; Sutcliffe CG; Higgins YM; Torbenson MS; Brinkley SC; Moore RD; Thomas DL; Sulkowski MS
JAMA; 2012 Jul; 308(4):370-8. PubMed ID: 22820790
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection.
Ioannou GN; Bryson CL; Weiss NS; Miller R; Scott JD; Boyko EJ
Hepatology; 2013 Jan; 57(1):249-57. PubMed ID: 22532055
[TBL] [Abstract][Full Text] [Related]
14. Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.
Lo Re V; Kallan MJ; Tate JP; Localio AR; Lim JK; Goetz MB; Klein MB; Rimland D; Rodriguez-Barradas MC; Butt AA; Gibert CL; Brown ST; Park L; Dubrow R; Reddy KR; Kostman JR; Strom BL; Justice AC
Ann Intern Med; 2014 Mar; 160(6):369-79. PubMed ID: 24723077
[TBL] [Abstract][Full Text] [Related]
15. Effect of Viral Replication and Liver Fibrosis on All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis B Virus-Coinfected Individuals: A Retrospective Analysis of a 15-Year Longitudinal Cohort.
Dezanet LNC; Kassime R; Miailhes P; Lascoux-Combe C; Chas J; Maylin S; Gabassi A; Rougier H; Delaugerre C; Lacombe K; Boyd A
Clin Infect Dis; 2022 Mar; 74(6):1012-1021. PubMed ID: 34197574
[TBL] [Abstract][Full Text] [Related]
16. Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons.
Ryom L; Lundgren JD; De Wit S; Kovari H; Reiss P; Law M; El-Sadr W; Monforte AD; Mocroft A; Smith C; Fontas E; Dabis F; Phillips A; Sabin C;
AIDS; 2016 Jul; 30(11):1731-43. PubMed ID: 26752282
[TBL] [Abstract][Full Text] [Related]
17. Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.
García-García JA; Romero-Gómez M; Girón-González JA; Rivera-Irigoin R; Torre-Cisneros J; Montero JL; González-Serrano M; Andrade RJ; Aguilar-Guisado M; Grilo I; Martín-Vivaldi J; Salmerón J; Caballero-Granado FJ; Macías J; Vergara-López S; Pineda JA; ;
AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1236-41. PubMed ID: 17209765
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of liver transplantation in human immunodeficiency virus/hepatitis B virus coinfected patients in China.
Tang J; Weng R; Fang T; Zhang K; Yan X; Jin X; Xie L; Zhao D
BMC Infect Dis; 2024 Apr; 24(1):383. PubMed ID: 38589801
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma in patients coinfected with hepatitis B or C and HIV: more aggressive tumor behavior?
Saud LRC; Chagas AL; Maccali C; Pinto PVA; Horvat N; Alencar RSSM; Tani CM; Abdala E; Carrilho FJ
Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):583-588. PubMed ID: 33560682
[TBL] [Abstract][Full Text] [Related]
20. End-stage liver disease: prevalence, risk factors and clinical characteristics in a cohort of HIV-HCV coinfected Han Chinese.
Deng L; Gui X; Xiong Y; Gao S; Yang R; Rong Y; Hu J; Yan Y
Clin Res Hepatol Gastroenterol; 2012 Dec; 36(6):574-82. PubMed ID: 22481087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
